Last reviewed · How we verify
NCT04125537
Pathways Project: Kidney Supportive Care
trial testing IHI Breakthrough Collaborative Model in Kidney Diseases in 476 participants. Completed in 31 October 2020.
31 August 2020
Quick facts
| Lead sponsor | George Washington University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 476 |
| Start date | 1 November 2018 |
| Primary completion | 31 August 2020 |
| Estimated completion | 31 October 2020 |
| Sites | 13 locations across United States |
Drugs / interventions tested
- IHI Breakthrough Collaborative Model
Conditions studied
- Kidney Diseases — all drugs for Kidney Diseases →
- Chronic Kidney Diseases — all drugs for Chronic Kidney Diseases →
- End Stage Renal Disease — all drugs for End Stage Renal Disease →
- End Stage Renal Disease on Dialysis — all drugs for End Stage Renal Disease on Dialysis →
Sponsor
George Washington University
Who can join
18 and older, any sex, with Kidney Diseases or Chronic Kidney Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Pathways Collaborative is the first attempt to implement supportive (palliative) kidney care at multiple sites in the United States. While supportive kidney care is growing in other countries, notably Canada, Australia, and Great Britain, it is not yet known how to integrate it into the unique nephrology environment in the United States. In Phase 1 of Pathways (completed), we developed an evidence-based change packet of 14 best practices for integrating supportive care practices into the continuum of care for patients with end stage kidney disease (ESKD). In Phase 2 (described in this application), we will conduct a learning collaborative to help up to 15 dialysis and CKD centers implement these best practices. The learning collaborative is based on the IHI Collaborative Model for Achieving Breakthrough Improvement. This model is a tested systematic approach to quality improvement designed to help organizations close the gap between current and future practice based on evidence-based best practices. The Pathways Project faculty will work with up to 15 change teams at dialysis centers to create a system to identify seriously ill patients with kidney disease; conduct conversations with them so that their values, preferences, and goals for current and future medical treatment are known and respected; assess and address patients' physical, psychological and spiritual needs; and coordinate care throughout the healthcare system so patients receive only the care they want in settings in which they wish to be.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Implementation and Effectiveness of a Learning Collaborative to Improve Palliative Care for Seriously Ill Hemodialysis Patients.
Kurella Tamura M, Holdsworth L, Stedman M, Aldous A, et al · · 2022 · cited 11× · PMID 36104084 · DOI 10.2215/cjn.00090122 -
Pathways Project: Development of a Multimodal Innovation To Improve Kidney Supportive Care in Dialysis Centers.
Lupu DE, Aldous A, Harbert G, Kurella Tamura M, et al · · 2021 · cited 8× · PMID 35368811 · DOI 10.34067/kid.0005892020 -
Pathways Project Pragmatic Lessons Learned: Integrating Supportive Care Best Practices into Real-World Kidney Care.
Moss AH, Harbert G, Aldous A, Anderson E, et al · · 2023 · cited 4× · PMID 37889550 · DOI 10.34067/kid.0000000000000277 -
"Diving in the deep-end and swimming": a mixed methods study using normalization process theory to evaluate a learning collaborative approach for the implementation of palliative care practices in hemodialysis centers.
Holdsworth LM, Stedman M, Gustafsson ES, Han J, et al · · 2023 · cited 2× · PMID 38082293 · DOI 10.1186/s12913-023-10360-7
Verify or expand the search:
- PubMed search for NCT04125537
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Kidney Diseases
Currently open trials in the same condition.
- NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting
- NCT07217535 — Rutgers University Study of the Genetics of Kidney Disease · recruiting
- NCT06858319 — Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy. · Phase 3 · recruiting
- NCT06798909 — Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients · Phase 3 · recruiting
- NCT06759077 — Cardio Protective Effect of SGL2I in Hemodialysis Patients and Its Impact on Patient Quality of Life · Phase 3 · active not recruiting
Other George Washington University trials
Trials by the same sponsor.
- NCT07279129 — Decision Support Tool to Integrate PrEP Into Emergency Departments · Phase 1 · not yet recruiting
- NCT07524309 — Self-Help Plus Pilot Study, Colombia: Train2Care · NA · not yet recruiting
- NCT07249008 — NSS Grocery Store Brazil · NA · recruiting
- NCT07000513 — HIV Self-Testing and Long-Acting Injectables for HIV Treatment and Prevention Among Commercial Minibus Drivers (I-TEST L · Phase 4 · not yet recruiting
- NCT07079306 — ChatGPT-Supported Text Messaging Program for Smoking Cessation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04125537 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by George Washington University
- Last refreshed: 13 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04125537.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing